These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 15546950)

  • 1. Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD.
    Ermann J; Hoffmann P; Edinger M; Dutt S; Blankenberg FG; Higgins JP; Negrin RS; Fathman CG; Strober S
    Blood; 2005 Mar; 105(5):2220-6. PubMed ID: 15546950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Hoffmann P; Ermann J; Edinger M; Fathman CG; Strober S
    J Exp Med; 2002 Aug; 196(3):389-99. PubMed ID: 12163567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Third-party regulatory T cells prevent murine acute graft-versus-host disease.
    Lim JY; Im KI; Song Y; Kim N; Nam YS; Jeon YW; Cho SG
    Korean J Intern Med; 2018 Sep; 33(5):980-989. PubMed ID: 29050459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.
    Schneidawind D; Baker J; Pierini A; Buechele C; Luong RH; Meyer EH; Negrin RS
    Blood; 2015 May; 125(22):3491-500. PubMed ID: 25795920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
    Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
    Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential.
    Fu S; Yopp AC; Mao X; Chen D; Zhang N; Chen D; Mao M; Ding Y; Bromberg JS
    Am J Transplant; 2004 Jan; 4(1):65-78. PubMed ID: 14678036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
    Jones SC; Murphy GF; Korngold R
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells.
    Riegel C; Boeld TJ; Doser K; Huber E; Hoffmann P; Edinger M
    Leukemia; 2020 Mar; 34(3):895-908. PubMed ID: 31719679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of donor Treg cells on GVHD and GVL effects after allogeneic bone marrow transplantation in mice].
    Cao J; Chen C; Zeng LY; Li ZY; Cheng H; Pan XY; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):181-4. PubMed ID: 20137143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.
    Taylor PA; Panoskaltsis-Mortari A; Swedin JM; Lucas PJ; Gress RE; Levine BL; June CH; Serody JS; Blazar BR
    Blood; 2004 Dec; 104(12):3804-12. PubMed ID: 15292057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superagonistic CD28 stimulation of allogeneic T cells protects from acute graft-versus-host disease.
    Beyersdorf N; Ding X; Hünig T; Kerkau T
    Blood; 2009 Nov; 114(20):4575-82. PubMed ID: 19721011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.
    Albert MH; Liu Y; Anasetti C; Yu XZ
    Eur J Immunol; 2005 Sep; 35(9):2598-607. PubMed ID: 16078276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.
    Pillai AB; George TI; Dutt S; Strober S
    Blood; 2009 Apr; 113(18):4458-67. PubMed ID: 19221040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
    Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
    Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.
    Taylor PA; Lees CJ; Blazar BR
    Blood; 2002 May; 99(10):3493-9. PubMed ID: 11986199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
    Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
    J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of T-regulatory cells, induced by immature dendritic cells, which inhibit enteroantigen-reactive colitis-inducing T-cell responses in vitro and in vivo.
    Gad M; Kristensen NN; Kury E; Claesson MH
    Immunology; 2004 Dec; 113(4):499-508. PubMed ID: 15554928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of graft-versus-host disease by a novel immunosuppressant, (5R)-5-hydroxytriptolide (LLDT-8), through expansion of regulatory T cells.
    Tang W; Yang Y; Zhang F; Li YC; Zhou R; Wang JX; Zhu YN; Li XY; Yang YF; Zuo JP
    Int Immunopharmacol; 2005 Dec; 5(13-14):1904-13. PubMed ID: 16275625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.